Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Déglon

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Revue Neurologique|April 5, 2024
Gene editing as a therapeutic strategy for spinocerebellar ataxia type-3N Déglon
The Journal of Gene Medicine|January 15, 2005
Viral vectors as tools to model and treat neurodegenerative disordersN Déglon, P Hantraye
Current Topics in Microbiology and Immunology|March 15, 2002
Lentiviruses as vectors for CNS diseasesN Déglon, P Aebischer
Immunogenetics|January 1, 1992
Multi-level regulation of Thy-1 antigen expression in mouse T lymphomasN J Fasel, N Déglon
The Journal of Gene Medicine|April 1, 2003
Optimization of human erythropoietin secretion from MLV-infected human primary fibroblasts used for encapsulated cell therapyF Schwenter, N Déglon, P Aebischer
Nature Medicine|July 30, 1999
Cellular xenotransplantationP Aebischer, A F Hottinger, N Déglon
Novartis Foundation Symposium|December 29, 2000
Gene transfer techniques for the delivery of GDNF in Parkinson's diseaseJ L Ridet, N Déglon, P Aebischer
Biochemical and Biophysical Research Communications|February 14, 1991
Translocation of the yeast dolichol-phosphate-mannose synthase into microsomal membranesN Déglon, A Krapp, C Bron, et al.
Neurobiology of Disease|October 12, 2004
Lentiviral nigral delivery of GDNF does not prevent neurodegeneration in a genetic rat model of Parkinson's diseaseC Lo Bianco, N Déglon, W Pralong, et al.
Neurobiology of Disease|March 14, 2017
Formation of hippocampal mHTT aggregates leads to impaired spatial memory, hippocampal activation and adult neurogenesisL C Schwab, K Richetin, R A Barker, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Revue Neurologique|April 5, 2024
Gene editing as a therapeutic strategy for spinocerebellar ataxia type-3N Déglon
The Journal of Gene Medicine|January 15, 2005
Viral vectors as tools to model and treat neurodegenerative disordersN Déglon, P Hantraye
Current Topics in Microbiology and Immunology|March 15, 2002
Lentiviruses as vectors for CNS diseasesN Déglon, P Aebischer
Immunogenetics|January 1, 1992
Multi-level regulation of Thy-1 antigen expression in mouse T lymphomasN J Fasel, N Déglon
The Journal of Gene Medicine|April 1, 2003
Optimization of human erythropoietin secretion from MLV-infected human primary fibroblasts used for encapsulated cell therapyF Schwenter, N Déglon, P Aebischer
Nature Medicine|July 30, 1999
Cellular xenotransplantationP Aebischer, A F Hottinger, N Déglon
Novartis Foundation Symposium|December 29, 2000
Gene transfer techniques for the delivery of GDNF in Parkinson's diseaseJ L Ridet, N Déglon, P Aebischer
Biochemical and Biophysical Research Communications|February 14, 1991
Translocation of the yeast dolichol-phosphate-mannose synthase into microsomal membranesN Déglon, A Krapp, C Bron, et al.
Neurobiology of Disease|October 12, 2004
Lentiviral nigral delivery of GDNF does not prevent neurodegeneration in a genetic rat model of Parkinson's diseaseC Lo Bianco, N Déglon, W Pralong, et al.
Neurobiology of Disease|March 14, 2017
Formation of hippocampal mHTT aggregates leads to impaired spatial memory, hippocampal activation and adult neurogenesisL C Schwab, K Richetin, R A Barker, et al.
Pageof 4